Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 8.01
-0.10 (-1.23%)
Feb 24, 2026, 12:16 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 131.08 million as of February 24, 2026. Its market cap has decreased by -13.17% in one year.
Market Cap
131.08M
Enterprise Value
129.39M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.01
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 131.08M, an increase of 40.92%. That is a compound annual growth rate of 2.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 128.33M | 13.75% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 591.88M |
| Captor Therapeutics Spolka Akcyjna | 455.57M |
| Bioceltix | 407.75M |
| BIOTON | 363.21M |
| Synthaverse | 261.85M |
| Molecure | 153.49M |
| Poltreg | 123.12M |
| NanoGroup | 83.39M |